Acyl-CoA Dehydrogenase, C-2 To C-3 Short Chain (Acads) Peptid
Kurzübersicht für Acyl-CoA Dehydrogenase, C-2 To C-3 Short Chain (Acads) Peptid (ABIN938486)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- FTSGDKIGCF ALSEPGNGSD AGAASTTARA EGDSWVLNGT KAWITNAWEA
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ACADS antibody,
Alternative Names: ACADS control peptide, ACADS antibody Blocking Peptide, Anti-ACADS Blocking Peptide, Acyl-Coenzyme A Dehydrogenase C-2 To C-3 Short Chain Blocking Peptide, ACAD3 Blocking Peptide, SCAD Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- ACADS (Acads) (Acyl-CoA Dehydrogenase, C-2 To C-3 Short Chain (Acads))
-
Hintergrund
- ACADS is a a tetrameric mitochondrial flavoprotein, which is a member of the acyl-CoA dehydrogenase family. This enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Mutations in this gene have been associated with Short Chain Acyl-CoA Dehydrogenase Deficiency. This gene encodes a a tetrameric mitochondrial flavoprotein, which is a member of the acyl-CoA dehydrogenase family. This enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Mutations in this gene have been associated with Short Chain Acyl-CoA Dehydrogenase Deficiency.
-
Molekulargewicht
- 42 kDa
Target
-